Results 11 to 20 of about 1,046,938 (380)

Biomarkers in sepsis. [PDF]

open access: yesCurrent Opinion in Pulmonary Medicine, 2013
Purpose of review: This review discusses the current developments in biomarkers for sepsis. Recent findings: With quantum leaps in technology, an array of biomarkers will become available within the next decade as point-of-care tools that will likely ...
Singer, M
core   +6 more sources

How to use biomarkers of infection or sepsis at the bedside: guide to clinicians

open access: yesIntensive Care Medicine, 2023
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. In this context, biomarkers could be considered as indicators of either infection or dysregulated host response or response to treatment and/or
P. Póvoa   +14 more
semanticscholar   +1 more source

The Endothelium in Sepsis [PDF]

open access: yesShock, 2016
Sepsis affects practically all aspects of endothelial cell (EC) function and is thought to be the key factor in the progression from sepsis to organ failure. Endothelial functions affected by sepsis include vasoregulation, barrier function, inflammation, and hemostasis.
Ince, Can   +8 more
openaire   +7 more sources

Sesamin attenuates intestinal injury in sepsis via the HMGB1/TLR4/IL-33 signalling pathway

open access: yesPharmaceutical Biology, 2020
Context Sepsis is currently one of the leading causes of death in intensive care units (ICUs). Sesamin was previously reported to inhibit inflammation. However, no studies have revealed the impact of sesamin on sepsis.
Zhi-Ling Li   +5 more
doaj   +1 more source

Epidemiology of intensive care unit-acquired sepsis in Italy: results of the SPIN-UTI network [PDF]

open access: yes, 2018
BACKGROUND: Sepsis is the major cause of mortality from any infectious disease worldwide. Sepsis may be the result of a healthcare associated infection (HAI): the most frequent adverse events during care delivery especially in Intensive Care Units ...
Agodi A   +15 more
core   +1 more source

Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial) [PDF]

open access: yes, 2012
Introduction: Several observational studies suggest that statins modulate the pathophysiology of sepsis and may prevent its progression. The aim of this study was to determine if the acute administration of atorvastatin reduces sepsis progression in ...
Barnett, A. H.   +11 more
core   +3 more sources

A snapshot of compliance with the sepsis six care bundle in two acute hospitals in the West Midlands, UK [PDF]

open access: yes, 2019
The sepsis six care bundle has been adopted by hospitals in England and Wales for the management of patients with sepsis, with the aim of increasing survival when all elements of the bundle are achieved.
Frankling, Catriona   +6 more
core   +1 more source

Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options

open access: yesMilitary Medical Research, 2022
Sepsis is a common complication of combat injuries and trauma, and is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection.
Di Liu   +15 more
semanticscholar   +1 more source

Lactate concentration gradient from right atrium to pulmonary artery: a commentary [PDF]

open access: yes, 2005
Inadequate myocardial performance is a common complication of severe sepsis. Studies in humans strongly argue against a decrease in coronary blood flow in the pathogenesis of this sepsis-induced cardiac injury.
Creteur, Jacques
core   +2 more sources

Home - About - Disclaimer - Privacy